Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Xintela

0.22 SEK

-0.45 %

Less than 1K followers

XINT

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Xintela

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)2.292.031.340.490.270.330.28
Shares71.9126.2152.1309.2422.1576.4861.3
Market cap164.2256.7204.1150.6113.8189.2244.6
Enterprise value163.8234.0194.2142.2---
EV/S4,310.1------
EV/EBITDAneg.neg.neg.neg.---
EV/EBITneg.neg.neg.neg.---
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B17.619.3051.7126.0525.98-31.80-46.39
P/S4,320.9---1,422.344.8107.2
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio54.5 %56.9 %16.0 %23.6 %23.8 %-24.0 %-18.2 %
Gearing ratio-39.5 %-----
Login required

This content is only available for logged in users

Create account
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.